Lecanemab, known as the brand name Leqembi, is the first drug approved by the FDA that slows cognitive decline in Alzheimer's patients — but there are still questions about the long-term efficacy and safety. NBC’s Maria Shriver reports for TODAY on the hope it’s giving to some families.
» Subscribe to TODAY: [ Ссылка ]
» Watch the latest from TODAY: [ Ссылка ]
About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website: [ Ссылка ]
Find TODAY on Facebook: [ Ссылка ]
Follow TODAY on Twitter: [ Ссылка ]
Follow TODAY on Instagram: [ Ссылка ]
» Stream TODAY All Day: [ Ссылка ]
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#health #fda #alzheimer
